Type to search

BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC | Pharmtech Focus
New Phase 3 Analyses Show That a Single Dose of REGEN-COV® (casirivimab and imdevimab) Provides Long-term Protection Against COVID-19 | Pharmtech Focus
First Monoclonal Antibody Treatment for COVID-19 Approved for Use in the UK | Pharmtech Focus